Artwork

Content provided by Middle Market Growth and Middle Market Growth Magazine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Middle Market Growth and Middle Market Growth Magazine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Cell Therapy: A New M&A Frontier

12:33
 
Share
 

Manage episode 380372821 series 1614268
Content provided by Middle Market Growth and Middle Market Growth Magazine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Middle Market Growth and Middle Market Growth Magazine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Cell and gene therapy technologies are ascendent, boosted by new developments in treatments for diseases like ovarian cancer and Parkinson’s disease, and by predictions of a meteoric rise in total market value in the next five years. Fabian Gerlinghaus, the co-founder and CEO of Cellares, a company that has developed a so-called “factory-in-a-box” for cell and gene therapy manufacturing, joins the podcast to share Cellares’ unique approach to developing successful cell therapies, the regulatory landscape and why investors should be watching this sector. *** The Middle Market Growth Conversations podcast is produced by the Association for Corporate Growth. To learn more about the organization and how to become a member, visit www.acg.org.
  continue reading

139 episodes

Artwork
iconShare
 
Manage episode 380372821 series 1614268
Content provided by Middle Market Growth and Middle Market Growth Magazine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Middle Market Growth and Middle Market Growth Magazine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Cell and gene therapy technologies are ascendent, boosted by new developments in treatments for diseases like ovarian cancer and Parkinson’s disease, and by predictions of a meteoric rise in total market value in the next five years. Fabian Gerlinghaus, the co-founder and CEO of Cellares, a company that has developed a so-called “factory-in-a-box” for cell and gene therapy manufacturing, joins the podcast to share Cellares’ unique approach to developing successful cell therapies, the regulatory landscape and why investors should be watching this sector. *** The Middle Market Growth Conversations podcast is produced by the Association for Corporate Growth. To learn more about the organization and how to become a member, visit www.acg.org.
  continue reading

139 episodes

Все серии

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide